GSK (GSK) – Accesswire
-
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
-
Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24
-
MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease; Expanding the Study for Patients 70 Years an
-
GSK and CureVac to Develop Next Generation MRNA COVID-19 Vaccines
Back to GSK Stock Lookup